Patient perception of Breezhaler and Ellipta device feedback mechanisms in COPD: the ADVANTAGE study.

CONCLUSION: COPD patients showed greater preference for the Breezhaler over the Ellipta inhaler for confidence of dose delivery and comfort of the mouthpiece. PMID: 29649916 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research